VT News
Buzz Osborne

Buzz Osborne

Ask VT AI
View News Summary
  • LSU officials in high-level discussions about Brian Kelly's future after a blowout loss to Texas A&M, with a potential buyout complicating matters.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Novartis is in advanced talks to acquire U.S. biotech Avidity Biosciences for over $12 billion, bolstering its neuroscience and RNA strategy.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • LSU officials in high-level discussions about Brian Kelly's future after a blowout loss to Texas A&M, with a potential buyout complicating matters.
  • Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
  • Novartis is in advanced talks to acquire U.S. biotech Avidity Biosciences for over $12 billion, bolstering its neuroscience and RNA strategy.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Buzz Osborne

Top Topics

Trending in U.S.

World

Sport